MHRA approves Cabotegravir : A game changer in HIV prevention
Approved by the MHRA, Cabotegravir 600 mg long-acting injection is the first injectable treatment approved to help prevent HIV-1 infection in the UK
In a...
GSK licenses Aurobindo, Cipla and Viatris to make generic versions of injectable cabotegravir
British drugmaker GSK has signed deals with three companies allowing them to make inexpensive generic versions of its long-acting HIV preventive medicine for use in...